A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 9,225 shares of NVO stock, worth $1.04 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
9,225
Previous 9,225 -0.0%
Holding current value
$1.04 Million
Previous $1.32 Million 16.57%
% of portfolio
0.88%
Previous 1.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $459,548 - $550,177
3,745 Added 68.34%
9,225 $1.32 Million
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $26,038 - $34,659
255 Added 4.88%
5,480 $703,000
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $458,650 - $550,976
5,225 New
5,225 $540,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track A. D. Beadell Investment Counsel, Inc. Portfolio

Follow A. D. Beadell Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.